Integration of modern data in WHO categorization of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosis.
The categorization of lymphosarcomas with immune markers has enriched the prognosis value of the WHO classification. The prolymphocytic (centrofollicular) B-type and the null lymphoblastic subtype have a good prognosis, while the (T- or B-) immunoblastic type and the T-lymphoblastic subtype have a poor prognosis.